Top compounds associated with response to ZNF230


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA PX-12 CTRPv2 pan-cancer AAC 0.1 0.0004
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA regorafenib CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA CP466722 GDSC1000 pan-cancer AAC 0.1 0.0005
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.12 0.0007
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.0008
Download CSV